With Just 7 Weeks Left in 2025, Rocket Lab Still Aims for 20+ Launches

Rocket Lab (RKLB) reported Q3 results that surpassed revenue and EPS expectations, driven by a 48% year-over-year sales increase. However, the stock declined following the announcement, primarily due to a substantial increase in year-to-date cash burn, reaching $207.6 million, and a further delay in the critical Neutron rocket's first flight, now anticipated to arrive at the launch pad in Q1 2026 with the actual launch occurring "thereafter." This continued cash consumption and repeated project delays are impacting investor sentiment despite strong top-line growth and long-term profitability projections tied to Neutron's eventual deployment.

Analysis

Rocket Lab (RKLB) reported Q3 results exceeding analyst expectations, with sales of $155 million (vs. $152 million forecast) and a loss of $0.03 per share (vs. $0.10 anticipated). Despite a 48% year-over-year sales increase and improved operating loss margin, the stock declined 3.7% post-announcement, signaling investor concern beyond headline beats.

The reported bottom-line improvement was largely due to accrued tax benefits; without these, losses would have increased to $59.3 million, indicating persistent operational challenges. Year-to-date cash burn more than doubled to $207.6 million, driven by $101 million in consumption and $106.6 million in capital investment, raising liquidity concerns.

A key negative driver is the further delay of the Neutron rocket's first flight, now expected to arrive at the launch pad in Q1 2026, with launch "sometime thereafter." This significant deviation from previous 2025 assurances impacts the timeline for a critical revenue driver, prolonging capital expenditure without anticipated returns.

While sales are growing and losses slowly shrinking, these delays and increased cash burn temper the positive long-term outlook. Analysts still project Neutron's eventual deployment to drive profitability within a year of operation, potentially by 2027, but the extended timeline warrants a re-evaluation of investment thesis and current valuation.

Key Decisions for Investors

• Investors should closely monitor Rocket Lab's escalating cash burn, which more than doubled to $207.6 million year-to-date, as it impacts future liquidity and funding requirements.
• Re-evaluate the investment thesis considering the Neutron rocket's further delay to Q1 2026 for pad arrival and subsequent launch, as this significantly pushes back the anticipated timeline for profitability, potentially to 2027.
• Assess current valuation multiples against the extended path to profitability and increased capital expenditure, adjusting for the heightened execution risk associated with project delays.